Malvern acquires GE business
5 Jun 2014
Malvern Instruments is set to acquire GE Healthcare Life Sciences’ MicroCal business.
Materials characterisation firm Malvern Instruments yesterday announced that it had entered into an agreement with GE Healthcare Life Sciences to acquire the company’s microcalorimetry business, MicroCal.
“Microcalorimetry is now an essential tool that is used at almost every stage of the drug discovery
Malvern MD Paul Walker
Subject to final regulatory approval, the deal is expected to close in the third quarter of this year.
MicroCal’s microcalorimetry systems are primarily designed to study proteins and biomolecules in drug discovery and development.
“Microcalorimetry is now an essential tool that is used at almost every stage of the drug discovery, development and formulation process,” said Paul Walker, managing director at Malvern Instruments.
“This addition to our business will have an immediate impact on Malvern’s ability to provide a complete range of instrumentation solutions and support across life science research and development,” Walker added.
MicroCal differential scanning calorimeters (DSC) and isothermal titration calorimeters (ITC) are traditionally used in areas from basic research to the discovery and development of small molecules, biotherapeutics and vaccines.
